Alto Neuroscience (ANRO) Stock Chart & Stock Price History $2.87 -0.04 (-1.37%) Closing price 03:59 PM EasternExtended Trading$2.87 +0.00 (+0.03%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alto Neuroscience Stock Price Performance The Alto Neuroscience (ANRO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 77.38%, with a year-to-date return of -32.15%. In the past month, the stock has increased 24.24%, reflecting recent market activity. As of the latest close, Alto Neuroscience traded at $2.91 with a market cap of $78.78 million and volume of 302,657 shares. Receive ANRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.50%1 Month Performance+24.24%3 Month Performance-10.45%Year-To-Date Performance-32.15%1 Year Performance-77.38% ANRO Stock Chart for Wednesday, May, 21, 2025 ANRO Chart by TradingView Alto Neuroscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$2.91$2.87-1.37%$2.97$2.77239,618 shs$77.70 million05/20/2025$2.56$2.91+13.67%$2.97$2.55302,657 shs$78.78 million05/19/2025$2.55$2.56+0.35%$2.60$2.4895,078 shs$69.30 million05/16/2025$2.44$2.55+4.55%$2.60$2.42217,225 shs$69.06 million05/15/2025$2.22$2.44+9.91%$2.45$2.16170,530 shs$66.06 million05/14/2025$2.36$2.22-5.93%$2.39$2.18186,265 shs$60.10 million05/13/2025$2.34$2.36+0.85%$2.38$2.34105,420 shs$63.89 million05/12/2025$2.21$2.34+5.88%$2.35$2.25125,622 shs$63.35 million05/09/2025$2.24$2.21-1.12%$2.25$2.19148,535 shs$59.83 million05/08/2025$2.17$2.24+3.00%$2.30$2.15160,993 shs$60.51 million Get the Latest News and Ratings for ANRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$2.17$2.17$2.25$2.12502,317 shs$58.75 million05/06/2025$2.34$2.17-7.07%$2.31$2.13216,183 shs$58.75 million05/05/2025$2.43$2.34-3.95%$2.45$2.3396,687 shs$63.21 million05/02/2025$2.45$2.43-0.57%$2.54$2.33157,599 shs$65.81 million05/01/2025$2.47$2.45-1.01%$2.50$2.38148,205 shs$66.19 million04/30/2025$2.44$2.47+1.23%$2.50$2.27134,668 shs$66.87 million04/29/2025$2.41$2.44+1.24%$2.46$2.31171,686 shs$66.06 million04/28/2025$2.33$2.41+3.66%$2.41$2.28151,224 shs$65.24 million04/25/2025$2.28$2.33+1.97%$2.35$2.20141,650 shs$62.94 million04/24/2025$2.28$2.28$2.34$2.24100,053 shs$61.72 million04/23/2025$2.24$2.28+1.74%$2.46$2.26149,412 shs$61.72 million04/22/2025$2.31$2.24-2.99%$2.37$2.14344,549 shs$60.67 million04/21/2025$2.25$2.31+2.90%$2.33$2.17183,511 shs$62.54 million Related Companies Cartesian Therapeutics Stock Chart 2seventy bio Stock Chart Alumis Stock Chart Inozyme Pharma Stock Chart Monte Rosa Therapeutics Stock Chart Terns Pharmaceuticals Stock Chart Palvella Therapeutics Stock Chart Lifecore Biomedical Stock Chart Tango Therapeutics Stock Chart Gossamer Bio Stock Chart Receive ANRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alto Neuroscience and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANRO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
